X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4552) 4552
Publication (283) 283
Book Review (24) 24
Book Chapter (22) 22
Conference Proceeding (14) 14
Dissertation (3) 3
Book / eBook (1) 1
Data Set (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (3808) 3808
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (2414) 2414
male (2288) 2288
mice (2015) 2015
neurosciences (2011) 2011
parkinson's disease (1723) 1723
mptp (1655) 1655
mice, inbred c57bl (1278) 1278
dopamine - metabolism (1218) 1218
index medicus (1089) 1089
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine - pharmacology (1082) 1082
parkinsons-disease (1061) 1061
disease models, animal (1039) 1039
dopamine (960) 960
humans (902) 902
rats (898) 898
female (749) 749
substantia-nigra (725) 725
corpus striatum - metabolism (716) 716
corpus striatum - drug effects (703) 703
neurons (697) 697
parkinson disease, secondary - chemically induced (680) 680
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mptp (662) 662
substantia nigra - drug effects (621) 621
brain (586) 586
biochemistry & molecular biology (581) 581
tyrosine 3-monooxygenase - metabolism (568) 568
pharmacology & pharmacy (554) 554
neurons - drug effects (548) 548
oxidative stress (530) 530
neurotoxicity (520) 520
substantia nigra - metabolism (496) 496
substantia nigra (469) 469
brain - metabolism (437) 437
neurons - metabolism (405) 405
dose-response relationship, drug (404) 404
clinical neurology (401) 401
brain - drug effects (397) 397
analysis (384) 384
motor activity - drug effects (382) 382
substantia nigra - pathology (380) 380
neuroprotective agents - pharmacology (362) 362
dopaminergic-neurons (344) 344
time factors (344) 344
striatum (340) 340
neurodegeneration (331) 331
neurology (331) 331
immunohistochemistry (326) 326
parkinsonism (326) 326
mpp (318) 318
parkinson disease - metabolism (316) 316
basal ganglia (315) 315
dopamine agents - pharmacology (315) 315
parkinsons disease (308) 308
neuroprotection (300) 300
behavior, animal - drug effects (292) 292
1-methyl-4-phenylpyridinium (287) 287
parkinson’s disease (280) 280
macaca fascicularis (275) 275
parkinsonian disorders - chemically induced (268) 268
disease (267) 267
mptp poisoning (266) 266
pyridines - pharmacology (263) 263
parkinson disease - pathology (259) 259
3,4-dihydroxyphenylacetic acid - metabolism (258) 258
monoamine oxidase - metabolism (253) 253
neurons - pathology (251) 251
mouse model (249) 249
apoptosis (247) 247
mouse (247) 247
parkinsonian disorders - metabolism (239) 239
nervous system (238) 238
parkinsonian disorders - physiopathology (238) 238
parkinson disease - drug therapy (237) 237
rat (232) 232
parkinson disease, secondary - physiopathology (229) 229
rat-brain (223) 223
neurotoxins - pharmacology (222) 222
alpha-synuclein (220) 220
pyridines - toxicity (219) 219
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine - administration & dosage (218) 218
corpus striatum - pathology (218) 218
parkinson disease, secondary - metabolism (216) 216
dopamine - physiology (215) 215
inhibition (211) 211
neurodegenerative diseases (210) 210
macaca mulatta (205) 205
in-vivo (203) 203
homovanillic acid - metabolism (202) 202
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine - metabolism (201) 201
mptp poisoning - metabolism (200) 200
parkinsonian disorders - pathology (200) 200
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine - adverse effects (196) 196
toxicity (193) 193
cell biology (192) 192
parkinson disease - physiopathology (192) 192
parkinsonian disorders - drug therapy (190) 190
parkinson disease (188) 188
rats, sprague-dawley (186) 186
tyrosine hydroxylase (186) 186
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4458) 4458
Russian (57) 57
Japanese (48) 48
Chinese (35) 35
Spanish (9) 9
French (5) 5
German (4) 4
Hungarian (2) 2
Polish (2) 2
Ukrainian (2) 2
Portuguese (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cellular and Molecular Life Sciences, ISSN 1420-682X, 04/2012, Volume 69, Issue 7, pp. 1153 - 1165
Journal Article
Journal Article
Journal of Neurochemistry, ISSN 0022-3042, 08/2010, Volume 114, Issue 3, pp. 717 - 727
J. Neurochem. (2010) 114, 717–727. The cellular localization of organic cation transporter (OCT) 1 and OCT2 in isolated brain microvessel endothelial cells... 
6‐tetrahydropyridine | blood‐brain barrier | N‐methyl‐4‐phenyl‐1 | organic cation transporter | blood-brain barrier | N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine | 1-METHYL-4-PHENYLPYRIDINIUM | N-methyl-4-phenyl-1 | BIOCHEMISTRY & MOLECULAR BIOLOGY | HYPOXIA | NEUROSCIENCES | RENAL PROXIMAL TUBULES | PROTECTS | 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE | 6-tetrahydropyridine | AMANTADINE | MICE | RAT-BRAIN | EXPRESSION | PARKINSONS-DISEASE | Parkinsonian Disorders - physiopathology | Binding, Competitive - physiology | Organic Cation Transport Proteins - metabolism | Rats, Wistar | Endothelial Cells - metabolism | Humans | Mice, Inbred C57BL | Cells, Cultured | Rats | Male | Organic Cation Transporter 2 | Blood-Brain Barrier - metabolism | Parkinsonian Disorders - metabolism | Biological Transport, Active | Animals | Capillaries - cytology | Dopamine - physiology | Neurotoxins - pharmacokinetics | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine - pharmacokinetics | Mice | Capillaries - metabolism | Octamer Transcription Factor-1 - metabolism | Dopamine - toxicity | Medical colleges | Amantadine | PET imaging | Analysis | Rodents | Pharmacy | Physiological aspects | Endothelium | Neurochemistry | Drugs | Brain | Dopamine | Toxicity | Index Medicus | Scanning | Confocal microscopy | Oct-2 protein | Endothelial cells | Western blotting | Microdialysis | Blood-brain barrier | MPP super(+) | Neostriatum | Kinetics | MPTP | Positron emission tomography
Journal Article
Brain, ISSN 0006-8950, 2012, Volume 135, Issue 11, pp. 3336 - 3347
Parkinson's disease is a neurodegenerative disorder that can, at least partly, be mimicked by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.... 
calcium-binding protein | Parkinson's disease | MPTP | S100B | S-100 PROTEIN | RECEPTOR | NEUROSCIENCES | CLINICAL NEUROLOGY | CEREBROSPINAL-FLUID S100B | SIGNALING PATHWAY | NEURON-SPECIFIC ENOLASE | SERUM-LEVELS | ACIDIC PROTEIN | INDUCED NEUROTOXICITY | UP-REGULATION | GLYCATION END-PRODUCTS | Tumor Necrosis Factor-alpha - metabolism | Up-Regulation | Substantia Nigra - pathology | Humans | Male | Nerve Growth Factors - metabolism | Substantia Nigra - metabolism | Case-Control Studies | Neuroprotective Agents - metabolism | Gliosis - pathology | S100 Proteins - genetics | Parkinson Disease - cerebrospinal fluid | Female | Parkinson Disease - metabolism | Receptor for Advanced Glycation End Products | Disease Models, Animal | Cell Line | Parkinson Disease - pathology | S100 Calcium Binding Protein beta Subunit | Mice, Inbred C57BL | S100 Proteins - metabolism | Parkinson Disease - genetics | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine - antagonists & inhibitors | Mice, Knockout | Animals | Nerve Growth Factors - genetics | Aged | Mice | Parkinson Disease - blood | Receptors, Immunologic - metabolism | Neuroprotection | Advanced glycosylation end products | Neurotoxins | Cytokines | Neurodegenerative diseases | Astrocytes | Substantia nigra | Inflammation | mRNA | Cerebrospinal fluid | S100 beta protein | Neurotoxicity | Calcium-binding protein | Movement disorders | Tumor necrosis factor- alpha
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 10/2002, Volume 99, Issue 22, pp. 14524 - 14529
Journal Article
Journal Article
Neuron, ISSN 0896-6273, 2003, Volume 37, Issue 6, pp. 899 - 909
Journal Article
Phytotherapy Research, ISSN 0951-418X, 02/2019, Volume 33, Issue 2, pp. 309 - 318
Parkinson is the second common neurodegenerative disease. The characteristics of Parkinson's disease (PD) are the dopamin neurons loss caused by... 
calycosin | 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP) | Toll‐like receptor (TLR)/nuclear factor kappa B (NF‐κB) pathway | mitogen‐activated protein kinase (MAPK) pathway | Parkinson's disease (PD) | Toll-like receptor (TLR)/nuclear factor kappa B (NF-κB) pathway | mitogen-activated protein kinase (MAPK) pathway | 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) | PRO-INFLAMMATORY CYTOKINES | APOPTOSIS | OXIDATIVE STRESS | CHEMISTRY, MEDICINAL | CANCER CELLS | SIGNALING PATHWAY | Toll-like receptor (TLR)/nuclear factor kappa B (NF-kappa B) pathway | IN-VIVO | TOLL-LIKE RECEPTORS | PHARMACOLOGY & PHARMACY | EXPRESSION | ALZHEIMERS | KINASES | Neuroprotective Agents - therapeutic use | Microglia - drug effects | Isoflavones - pharmacology | Cells, Cultured | Rats | Male | NF-kappa B - metabolism | PC12 Cells | Lipopolysaccharides | Parkinson Disease, Secondary - pathology | Animals | MAP Kinase Signaling System - drug effects | Neuroprotective Agents - pharmacology | Inflammation - drug therapy | Dopaminergic Neurons - drug effects | Parkinson Disease, Secondary - metabolism | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | Parkinson Disease, Secondary - prevention & control | Inflammation - prevention & control | Isoflavones - therapeutic use | Mice | Parkinson Disease, Secondary - chemically induced | Toll-Like Receptors - metabolism | Mitogen-Activated Protein Kinases - metabolism | Neuroprotection | Parkinson's disease | Parkinsons disease | Kinases | Tyrosine 3-monooxygenase | Proteins | Pathways | Rodents | Toll-like receptors | Movement disorders | Isoflavones | Cylinders | Dopamine receptors | Tyrosine | Signs and symptoms | CD11b antigen | Dopamine | Neurodegenerative diseases | Neurons | Hydroxylase | MAP kinase | Pharmacology | Inflammation | Microglia | Neurological diseases | Protein kinase | Cell lines | MPTP
Journal Article
Annals of the New York Academy of Sciences, ISSN 0077-8923, 10/2008, Volume 1139, Issue 1, pp. 318 - 330
Journal Article
Toxicology Letters, ISSN 0378-4274, 01/2016, Volume 243, pp. 7 - 21
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 2/2008, Volume 105, Issue 5, pp. 1716 - 1721
Journal Article